Ardent Health drops on $116 mln secondary offering
** Shares of hospital operator Ardent Health ARDT.N drop 15.1% to $15.07 premarket on Weds after $116 mln secondary offering pricing
** ARDT late Tues announced 8 mln shares, comprising sale of ~7.1 mln shares by affiliate of Equity Group Investments (EGI) and 863,281 shares by affiliate of Ventas VTR.N, at $14.50
** Offering price is 18.3% discount to stock's last close
** ARDT will concurrently repurchase 1.5 mln shares from the underwriters as part of offering
** JP Morgan and Barclays leading offering, along with seven other bookrunners
** Prior to offering, EGI-AM Investments owned 54.8% stake and Ventas held 6.6% stake in ARDT, according to the prospectus
** Brentwood, Tennessee-based ARDT has ~140.9 mln shares outstanding
** Through Tues, stock has doubled YTD including 47.5% surge in Nov
** Health insurers and hospital stocks rallied earlier this month after sweeping midterm election win by Democrats fueled hopes of sector-friendly policy changes
** Avg rating of 12 analysts covering ARDT is "buy"; median PT of $18 up from $13 a month ago, per LSEG data